In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 1, 2016, Pages 52-70

  Weber, Benedikt ^a,b   Kehl, Debora ^a,b   Bleul, Ulrich ^a   Behr, Luc ^c   Sammut, Sébastien ^c   Frese, Laura ^a,b   Ksiazek, Agnieszka ^a,b   Achermann, Josef ^d   Stranzinger, Gerald ^e   Robert, Jérôme ^a,b,f   Sanders, Bart ^g   Sidler, Michele ^a   Brokopp, Chad E ^a   Proulx, Steven T ^e   Frauenfelder, Thomas ^b   Schoenauer, Roman ^a,b   Emmert, Maximilian Y ^a,b   Falk, Volkmar ^a,b   Hoerstrup, Simon P ^a,b,h  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c INSTITUT MUTUALISTE MONTSOURIS   (France)

^d Genetica AG   (Switzerland)

^e ETH ZURICH   (Switzerland)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^g EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^h Center for Applied Biotechnology and Molecular Medicine (CABMM)   (Switzerland)

Author keywords

Amniotic fluid; Cardiovascular tissue engineering; Fetal model; Mesenchymal stem cells; Ovine in vivo model; Vascular graft

Indexed keywords

ANIMALS; CELL ENGINEERING; FABRICATION; FLOWCHARTING; FLUORIDATION; STEM CELLS; TISSUE; TISSUE ENGINEERING;

AMNIOTIC FLUID; CARDIOVASCULAR TISSUE ENGINEERING; FETAL MODELS; FLUID CELLS; IN-VITRO; IN-VIVO; MESENCHYMAL STEM CELL; OVINE IN-VIVO MODEL; VASCULAR GRAFTS; VIVO MODELS;

CELL CULTURE;

STAT3 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR NANOG; CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

AMNION FLUID DERIVED STEM CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BLOOD VESSEL GRAFT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARDIOVASCULAR TISSUE; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL LINEAGE; CELL VIABILITY; CONTROLLED STUDY; EPITHELIZATION; EWE; FEMALE; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESODERMAL CELL; MICROTECHNOLOGY; MYOFIBROBLAST; NONHUMAN; NUMERICAL CHROMOSOME ABERRATION; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SHEEP; STEM CELL; TISSUE ENGINEERING; AMNION; AMNION FLUID; ANIMAL; AUTOTRANSPLANTATION; BLOOD VESSEL PROSTHESIS; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELL SURVIVAL; CHEMISTRY; CHROMOSOME ABERRATION; CYTOLOGY; ENDOTHELIUM CELL; GENOTYPE; KARYOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; PROCEDURES; TISSUE SCAFFOLD;

AC133 ANTIGEN; AMNION; AMNIOTIC FLUID; ANIMALS; ANTIGENS, CD; BLOOD VESSEL PROSTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SHAPE; CELL SURVIVAL; CHROMOSOME ABERRATIONS; ENDOTHELIAL CELLS; FEMALE; GENOTYPE; GLYCOPROTEINS; KARYOTYPING; MESENCHYMAL STROMAL CELLS; MYOFIBROBLASTS; PEPTIDES; PHENOTYPE; PREGNANCY; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84954364863     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1781     Document Type: Article

References (56)

1. Bai J, Wang Y, Liu L, Chen J, Yang W, Gao L, et al. 2012; Human amniotic fluid-derived c-kit(+) and c-kit(-) stem cells: growth characteristics and some differentiation potential capacities comparison. Cytotechnology 13: 577-589.
2. Barnhart GR, Jones M, Ishihara T, et al. 1982; Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. Am J Pathol 106: 136-139.
3. Bazer FW, Spencer TE, Thatcher WW. 2011; Growth and development of the ovine conceptus. J Anim Sci 90: 159-170.
4. Ben-David U, Benvenisty N. 2011; The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11: 268-277.
5. Berardino MA. 2001; Animal cloning - the route to new genomics in agriculture and medicine. Differentiation 68: 67-83.
6. Bollini S, Cheung KK, Riegler J, et al. 2011; Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 8: 1985-1994..
7. Byun SO, Zhou H, Frampton CM, et al. 2010; No association between variation in the ovine calpastatin gene and either longevity or fertility in sheep. Anim Genet 41: 223-224.
8. Cananzi M, Atala A, De Coppi P. et al. 2009; Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 18: 17-27.
9. Carraro G, Perin L, Sedrakyan S, et al. 2008; Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26: 2902-2911.
10. Cesarone CF, Bolognesi C, Santi L. 1979; Improved microfluorometric DNA determination in biological material using 33258 Hoechst. Anal Biochem 100: 188-197.
11. Chen J, Lu Z, Cheng D, et al. 2011; Isolation and characterization of porcine amniotic fluid-derived multipotent stem cells. PLoS One 6: 19964.
12. Colosimo A, Curini V, Russo V, et al. 2013; Characterization, GFP gene nucleofection and allotransplantation in injured tendons of ovine amniotic fluid-derived stem cells. Cell Transplant 22: 99-117.
13. Da Sacco S, De Filippo RE, Perin L. 2011; Amniotic fluid as a source of pluripotent and multipotent stem cells for organ regeneration. Curr Opin Organ Transplant 16: 101-105.
14. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. 2007; Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106.
15. Emmert MY, Weber B, Wolint P, et al. 2013; Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study. PLoS One 8: e57759.
16. Farndale RW, Buttle DJ, Barrett AJ. 1986; Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883: 173-177.
17. Ge J, Cai H, Tan WS. 2011; Chromosomal stability during ex vivo expansion of UCB CD34(+) cells. Cell Prolif 44: 550-557.
18. Genead R, Danielsson C, Andersson AB, et al. 2010; Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood. Stem Cells Dev 19: 1601-1615.
19. Gosden C, Brock DJ. 1978; Combined use of alphafetoprotein and amniotic fluid cell morphology in early prenatal diagnosis of fetal abnormalities. J Med Genet 15: 262-270.
20. Gronthos S, McCarty R, Mrozik K, et al. 2009; Heat shock protein-90 beta is expressed at the surface of multipotential mesenchymal precursor cells: generation of a novel monoclonal antibody, STRO-4, with specificity for mesenchymal precursor cells from human and ovine tissues. Stem Cells 18: 1253-1262.
21. Guan X, Delo DM, Atala A, et al. 2011; In vitro cardiomyogenic potential of human amniotic fluid stem cells. J Tissue Eng Regen Med 5: 220-228.
22. Hauser PV, De Fazio R, Bruno S, et al. 2010; Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177: 2011-21.
23. Hipp J, Atala A. 2008; Sources of stem cells for regenerative medicine. Stem Cell Rev 4: 3-11.
24. Huszar G, Maiocco J, Naftolin F. 1980; Monitoring of collagen and collagen fragments in chromatography of protein mixtures. Anal Biochem 105: 424-429.
25. Josse C, Schoemans R, Niessen NA, et al. 2010; Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells. Stem Cells Dev 19: 1167-1173.
26. Klein JD, Turner CG, Steigman SA, et al. 2011; Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev 20: 969-976.
27. Kolambkar YM, Peister A, Soker S, et al. 2007; Chondrogenic differentiation of amniotic fluid-derived stem cells. J Mol Histol 38: 405-413.
28. Kotobuki N, Hirose M, Machida H, et al. 2005; Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng 11: 663-673.
29. Kunisaki SM, Fuchs JR, Steigman SA, et al. 2007; A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng 13: 2633-2644.
30. Lapa Pedreira DA, Quintero RA, Acácio GL, et al. 2011; Neoskin development in the fetus with the use of a three-layer graft: an animal model for in utero closure of large skin defects. J Matern Fetal Neonatal Med 24: 1243-8.
31. Lovell KL, Sprecher DJ, Ames NK, et al. 1995; Development and efficacy of ultrasound-guided fetal fluid aspiration techniques for prenatal fiagnosis of β-Mannosidosis. Theriogenology, 44: 517-527.
32. Ma X, Zhang S, Zhou J, et al. 2012; Clone-derived human AF-amniotic fluid stem cells are capable of skeletal myogenic differentiation in vitro and in vivo. J Tissue Eng Regen Med 6: 598-613.
33. Maraldi T, Riccio M, Resca E, et al. 2011; Human amniotic fluid stem cells seeded in fibroin scaffold produce in vivo mineralized matrix. Tissue Eng Part A 17: 2833-2843.
34. Mauro A, Turriani M, Ioannoni A, et al. 2010; Isolation, characterization, and in vitro differentiation of ovine amniotic stem cells. Vet Res Commun 34: 25-28.
35. McCarty RC, Gronthos S, Zannettino AC, et al. 2009; Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 219: 324-333.
36. Mol A, van Lieshout MI, Dam-de Veen CG, et al. 2005; Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26: 3113-3121.
37. Muller F, Dommergues M, Ville Y, et al. 1994; Amniotic fluid digestive enzymes: diagnostic value in fetal gastrointestinal obstructions. Prenat Diagn 14: 973-979.
38. Muraki K, Hirose M, Kotobuki N, et al. 2006; Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Eng 12: 1711-1719.
39. Park SB, Seo MS, Kang JG, et al. 2011; Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. Cytotherapy 13: 341-349.
40. Parolini O, Soncini M, Evangelista M, et al. 2009; Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 4: 275-291.
41. Perin L, Giuliani S, Jin D, et al. 2007; Renal differentiation of amniotic fluid stem cells. Cell Prolif 40: 936-948.
42. Porada CD, Harrison-Findik DD, Sanada C, et al. 2008; Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp Hematol 36: 1739-1749.
43. Schmidt D, Mol A, Neuenschwander S, et al. 2005; Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 27: 795-800.
44. Schmidt D, Asmis LM, Odermatt B, et al. 2006; Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors. Ann Thorac Surg 82: 1465-1471.
45. Schmidt D, Achermann J, Odermatt B, et al. 2007; Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 11: 64-70.
46. Schmidt D, Achermann J, Odermatt B, 2008; Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis 17: 446-455.
47. Schneider OD, Mohn D, Fuhrer R, et al. 2011; Biocompatibility and bone formation of flexible, cotton wool-like PLGA/calcium phosphate nanocomposites in sheep. Open Orthop J 16: 63-71.
48. Schoeberlein A, Holzgreve W, Dudler L, et al. 2005; Tissue-specific engraftment after in utero transplantation of allogeneic mesenchymal stem cells into sheep fetuses. Am J Obstet Gynecol 192: 1044-1452.
49. Shaw SS, Bollini S, Abi Nader K, et al. 2010; Autologous transplantation of amniotic fluid derived mesenchymal stem cells into sheep fetuses. Cell Transplant 31: 1133-1139.
50. Sun H, Feng K, Hu J, et al. 2010; Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 31: 1133-1139.
51. Turner CG, Klein JD, Steigman SA, et al. 2011; Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg 46: 57-61.
52. van Geemen D, Driessen-Mol A, Grootzwagers LG, et al. 2012; Variation in tissue outcome of ovine and human engineered heart valve constructs: relevance for tissue engineering. Regen Med 7: 59-70.
53. Wahlström J. 1974; The quantity of viable cells at various stages of gestation. Humangenetik, 22: 335-342.
54. Weber B, Zeisberger SM, Hoerstrup SP. et al. 2011a; Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta 32: 316-319.
55. Weber B, Schoenauer R, Papadopulos F, et al. 2011b; Engineering of living autologous human umbilical cord cell-based septal occluder membranes using composite PGA-P4HB matrices. Biomaterials 32: 9630-9641.
56. Weber B, Emmert MY, Behr L, et al. 2012; Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials 33: 4031-4043.